PIONEER AF-PCI: Rivaroxaban + P2Y12 Inhibitor clopidogrel ~94% or Rivaroxaban + DAPT vs. Warfarin + DAPT in Patients with Atrial
Studio PIONEER AF-PCI nei pazienti con fibrillazione atriale sottoposti ad angioplastica coronarica: quali risvolti clinici? - ATBV
Antithrombotic Strategy in Patients With AF and Recent ACS or PCI: Primary Results of the AUGUSTUS Trial - American College of Cardiology
Antithrombotic therapy in patients with non-valvular atrial fibrillation undergoing percutaneous coronary intervention: should we change our practice after the PIONEER AF-PCI and RE-DUAL PCI trials? | SpringerLink
PIONEER AF-PCI Trial: Inclusion and Main Exclusion Criteria and Study Design | Radcliffe Cardiology
Prevention of Bleeding in Patients With Atrial Fibrillation Undergoing PCI ( PIONEER): Three May End Up Being a Crowd - Samuel A. Berkman, 2018
Adobe AudienceManager
The PIONEER Trial: Rivaroxaban in Patients With ACS and Atrial Fibrillation: Design, Rationale, and Status | tctmd.com
![臨床藥學] PIONEER AF-PCI：心房顫動合併冠心症接受心導管治療，Rivaroxaban降低心導管後出血風險(Bleeding in Patients with AF Undergoing PCI) - NEJS](https://4.bp.blogspot.com/-ki6zrPeBWxI/WCpzKF9yAbI/AAAAAAABXc4/evvkGYfo10QidY4RLi4YXaODj2ZOT5-hgCLcB/s1600/NEJS%2B20160905.png "臨床藥學] PIONEER AF-PCI：心房顫動合併冠心症接受心導管治療，Rivaroxaban降低心導管後出血風險(Bleeding in Patients with AF Undergoing PCI) - NEJS")
臨床藥學] PIONEER AF-PCI：心房顫動合併冠心症接受心導管治療，Rivaroxaban降低心導管後出血風險(Bleeding in Patients with AF Undergoing PCI) - NEJS
Spotlight on unmet needs in stroke prevention: The PIONEER AF-PCI, NAVIGATE ESUS and GALILEO trials
New Perspectives in AF and PCI: Implications for the Practicing Physician. - ppt download
Anticoagulation in patients with non-valvular AF undergoing PCI: clinical evidence from PIONEER AF-PCI - The British Journal of Cardiology
3 0 Patients undergoing PCI with atrial fibrillation AF
RE-DUAL PCI™ vs PIONEER AF-PCI™
Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI | NEJM
Advances in Coronary Artery Disease: Moving Beyond Antiplatelet Therapy (Transcript)
Atrial Fibrillation and PCI - ppt download
Changes of antithrombotic prescription in atrial brillation patients with acute coronary syndrome or percutaneous coronary inter
Recurrent Hospitalization Among Patients With Atrial Fibrillation Undergoing Intracoronary Stenting Treated With 2 Treatment Strategies of Rivaroxaban or a Dose-Adjusted Oral Vitamin K Antagonist Treatment Strategy | Circulation
Davide Capodanno on Twitter: "#PIONEER, #REDUAL, #AUGUSTUS, and #ENTRUST in a nutshell: The Fab Four in #AF #PCI https://t.co/ve7enVHwM7" / Twitter
Direct oral anticoagulants versus standard triple therapy in atrial fibrillation and PCI: meta-analysis | Open Heart
Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI | Challenges in Cardiology
Xarelto® (rivaroxaban) – PIONEER
Patients with AF undergoing PCI | Thrombosis Adviser
PIONEER AF-PCI Trial: Inclusion and Main Exclusion Criteria and Study... | Download Scientific Diagram
